Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 2,153 shares, a drop of 54.3% from the August 15th total of 4,707 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 46,203 shares, the short-interest ratio is currently 0.0 days.
Healthcare Capital Acquisition Price Performance
Shares of NASDAQ HCAC traded up $0.01 during mid-day trading on Tuesday, reaching $10.12. 104,183 shares of the company’s stock were exchanged, compared to its average volume of 89,832. The firm has a market capitalization of $377.36 million, a price-to-earnings ratio of 202.30 and a beta of 0.41. Healthcare Capital Acquisition has a 52 week low of $9.91 and a 52 week high of $10.11. The firm has a 50-day moving average price of $10.08 and a two-hundred day moving average price of $10.02.
Wall Street Analyst Weigh In
Separately, Weiss Ratings assumed coverage on Healthcare Capital Acquisition in a research note on Monday, August 24th. They issued a “sell (e+)” rating on the stock. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Healthcare Capital Acquisition stock. BlueCrest Capital Management Ltd bought a new stake in shares of Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 250,000 shares of the company’s stock, valued at approximately $2,510,000. BlueCrest Capital Management Ltd owned 0.67% of Healthcare Capital Acquisition as of its most recent SEC filing. 66.82% of the stock is owned by institutional investors.
About Healthcare Capital Acquisition
Healthcare Capital Acquisition Corp. (NASDAQ: HCAC) was a special purpose acquisition company (SPAC) formed to pursue a business combination with a company in the healthcare industry. As a blank-check company, it did not operate a healthcare business or offer its own products and services.
Its investment focus was broadly oriented toward healthcare, life sciences, medical technology, pharmaceuticals, biotechnology, diagnostics and related sectors. The company’s principal activity was identifying a suitable target, negotiating a transaction and obtaining approval from its shareholders and other stakeholders.
Because Healthcare Capital Acquisition Corp.
See Also
- Five stocks we like better than Healthcare Capital Acquisition
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Healthcare Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
